Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 20, Issue 12, 2012, Pages 1026-1035

  Dar Nimrod, Ilan ^a   Chapman, Benjamin P ^b   Franks, Peter ^e   Robbins, John ^e   Porsteinsson, Anton ^c   Mapstone, Mark ^d   Duberstein, Paul R ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Laboratory of Personality and Development   (United States)

^c Research and Education Program   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; APOE genotype; cognitive function; G E interaction; personality

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ALZHEIMER'S DISEASE ASSESSMENT SCALE COGNITIVE; ARTICLE; COGNITION; CONSCIOUSNESS; CONTROLLED STUDY; EXTRAVERSION; FEMALE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROSIS; ONSET AGE; OUTCOME ASSESSMENT; PERSONALITY; PHENOTYPE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE;

EID: 84871006439     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318267016b     Document Type: Article

References (47)

1. Alzheimer's Association: Alzheimer's disease facts and figures. Alzheimer's Dement: J Alzheimer's Assoc 2012; 8:131-168
2. N̈aslund J, Haroutunian V, Mohs R, et al: Correlation between elevated levels of amyloid-peptide in the brain and cognitive decline. JAMA 2000; 283(12):1571
3. Saunders A, Strittmatter W, Schmechel D, et al: Association of apolipoprotein E allele 4 with late onset familial and sporadic Alzheimer's disease. Neurology 1993; 43(8):1467
4. Bird TD: Genetic aspects of Alzheimer disease. Genet Med 2008; 10(4):231-239 (Pubitemid 351544124)
5. Small BJ, Rosnick CB, Fratiglioni L, et al: Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19(4):592
6. Corsentino EA, Sawyer K, Sachs-Ericsson N, et al: Depressive symptoms moderate the influence of the apolipoproteinE ε4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychol 2009; 17(2):155
7. Chapman BP, Shah M, Friedman B, et al: Personality traits predict emergency department utilization over 3 years in older patients. Am J Geriatr Psychiatry 2009; 17(6):526-535
8. Chapman BP, Roberts BW, Duberstein PR: Personality and longevity: knowns, unknowns, and implications for public health and personalized medicine. J Aging Res 2011;759170. Epub July 10, 2011
9. Wilson RS, Schneider JA, Arnold SE, et al: Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry 2007; 64(10):1204-1212 (Pubitemid 47529345)
10. Costa PT, McCrae RR: Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI). Odessa, FL, Psychological Assessment Resources, 1992
11. McCrae RR, Costa PT, Jr.: The five-factor theory of personality, in Handbook of Personality Psychology: Theory and Research, 3rd ed. Edited by John OP, Robins RW, Pervin LA. New York, Guilford Press, 2008, pp 159-181
12. Lucas RE, Diener E, Grob A, et al: Cross-cultural evidence for the fundamental features of extraversion. J Pers Soc Psychol 2000; 79(3):452
13. Boyle LL, Lyness JM, Duberstein PR, et al: Trait neuroticism, depression, and cognitive function in older primary care patients. Am J Geriatr Psychiatry 2010; 18(4):305-312
14. Chapman BP, Duberstein PR, Tindle HA, et al: Personality predicts cognitive function over seven years in older persons. Am J Geriatr Psychiatry, 2012; 20(7):612-621
15. Duberstein PR, Chapman BP, Tindle HA, et al: Personality and risk for Alzheimer's disease in adults 72 years of age and older: a 6-year follow-up. Psychol Aging 2011; 26:351-362
16. Hothorn T, Bretz F, Westfall P: Simultaneous inference in general parametric models. Biom J 2008; 50(3):346-363
17. Caselli RJ, Reiman EM, Hentz JG, et al: A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes. J Neuropsychiatry Clin Neurosci 2004; 16(3):320
18. Sandstr̈om A, Peterson J, Sandstr̈om E, et al: Cognitive deficits in relation to personality type and hypothalamic-pituitary-adrenal (HPA) axis dysfunction in women with stress-related exhaustion. Scand J Psychol 2011; 52(1):71-82
19. O'Brien J, Ames D, Schweitzer I, et al: Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychol Med 1996; 26(1): 7-14 (Pubitemid 26031799)
20. DeKosky ST, Williamson JD, Fitzpatrick AL, et al: Ginkgo biloba for prevention of dementia. JAMA 2008; 300(19):2253
21. DeKosky ST, Fitzpatrick A, Ives DG, et al: The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 2006; 27(3):238-253
22. Kuller LH, Shemanski L, Manolio T, et al: Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke 1998; 29(2):388-398 (Pubitemid 28086681)
23. Irwin M, Artin KH, Oxman MN: Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 1999; 159(15):1701-1704 (Pubitemid 29379131)
24. Gustafson D, Rothenberg E, Blennow K, et al: An 18-year followup of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163(13):1524-1529
25. Gustafson D, Melchior L, Eriksson E, et al: The ACE insertion deletion polymorphism relates to dementia by metabolic phenotype, APOE4, and age of dementia onset. Neurobiol Aging 2010; 31(6):910-916
26. RosenWG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141(11):1356
27. Perneczky R, Pohl C, Sorg C, et al: Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues. Age Ageing 2006; 35:240-245
28. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease. Neurology 1984; 34:939-944
29. Erkinjuntti T: Clinical criteria for vascular dementia: the NINDSAIREN criteria. Dement Geriatr Cogn Disord 1994; 5(3-4):189-192 (Pubitemid 24151545)
30. Chui HC, Mack W, Jackson JE, et al: Clinical criteria for the diagnosis of vascular dementia. Arch Neurol 2000; 57(2):191-196
31. Bates D, Maechler M, Bolker B: Lme4: linear mixed-effects models using S4 classes. R package version 0.999375-39, 2011
32. Wilson R, Bennett D, Bienias J, et al: Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002; 59(12):1910
33. Yaffe K, Weston A, Graff-Radford NR, et al: Association of plasma-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 2011; 305(3):261
34. Peskind ER, Wilkinson CW, Petrie EC, et al: Increased CSF cortisol in AD is a function of APOE genotype. Neurology 2001; 56(8):1094-1098 (Pubitemid 32336320)
35. Fuchs E, Fl̈ugge G: Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev 1998; 23(2):295-300 (Pubitemid 29011632)
36. Dong H, Csernansky JG: Effects of stress and stress hormones on amyloid-β protein and plaque deposition. J Alzheimer's Dis 2009; 18(2):459-469
37. Cohen NJ, Eichenbaum H: Memory, Amnesia, and the Hippocampal System. Cambridge, MA, MIT Press, 1995
38. Roberts BW, Walton KE, Viechtbauer W. Patterns of mean-level change in personality traits across the life course: a meta-analysis of longitudinal studies. Psychol Bull 2006; 132(1):1-25 (Pubitemid 43172350)
39. Brosschot JF, Van Der Doef M: Daily worrying and somatic health complaints: Testing the effectiveness of a simple worry reduction intervention. Psychol Health 2006; 21(1):19-31 (Pubitemid 43024349)
40. Gaylord C, Orme-Johnson D, Travis F: The effects of the transcendental mediation technique and progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults. Int J Neurosci 1989; 46(1-2):77-86
41. Infante JR, Peran F, Martinez M, et al: ACTH and β-endorphin in transcendental meditation. Physiol Behav 1998; 64(3):311-315
42. Tang TZ, DeRubeis RJ, Hollon SD, et al: Personality change during depression treatment: a placebo-controlled trial. Arch Gen Psychiatry 2009; 66(12):1322-1330
43. Jackson J, Hill P, Payne B, et al: Can an old dog learn (and want to experience) new tricks? Cognitive training increases openness to experience in older adults. Psych Aging 2012; 27(2):286-292
44. Dar-Nimrod I, Heine SJ: Some thoughts on essence placeholders, interactionism, and heritability: reply to Haslam and Turkheimer. Psychol Bull 2011; 137(5):829-833
45. Dar-Nimrod I, Heine SJ: Genetic essentialism: on the deceptive determinism of DNA. Psychol Bull 2011; 137(5):800-818
46. Dar-Nimrod I, Heine SJ: Exposure to scientific theories affects women's math performance. Science 2006; 314(5798):435-435
47. McClelland GH, Judd CM: Statistical difficulties of detecting interactions and moderator effects. Psychol Bull 1993; 114(2):376